Galmed Pharmaceuticals Ltd.
GLMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,892 | -$2,495 | -$1,104 | -$3,209 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $105 | $100 | $101 | $116 |
| Change in WC | -$65 | $628 | -$141 | -$580 |
| Other Non-Cash | -$83 | $499 | -$23 | $1,704 |
| Operating Cash Flow | -$1,935 | -$1,268 | -$1,167 | -$1,969 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$3 | -$4,554 | -$1,032 | -$3,036 |
| Inv. Sales/Matur. | $0 | -$15 | $801 | -$263 |
| Other Inv. Act. | $0 | $0 | $0 | -$250 |
| Investing Cash Flow | -$3 | -$4,569 | -$231 | -$3,549 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $289 | $6,035 | $1,514 | $4,848 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$4,400 |
| Financing Cash Flow | $289 | $6,035 | $1,514 | $448 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,649 | $198 | $116 | -$5,070 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,087 | $4,889 | $4,773 | $9,843 |
| End Cash | $3,438 | $5,087 | $4,889 | $4,773 |
| Free Cash Flow | -$1,935 | -$1,268 | -$1,167 | -$1,969 |